Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

By sjmartinez • July 24, 2024

Karpouzas GA, Ormseth SR, van Riel PLCM, Gonzalez-Gay MA, Corrales A, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Tsang L, Hitchon C, El-Gabalawy H, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, Misra DP, Hauge EM, Kitas G. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD Open. 2024 Jul 23;10(3):e004546. doi: 10.1136/rmdopen-2024-004546. PMID: 39043615.

Tags: Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Inflammation, Publications, Rheumatoid, Rheumatology

Gestational exposure to PM2.5, NO2, and sex steroid hormones: Identifying critical windows of exposure in the Rochester UPSIDE Cohort

Kahwaji M, Duttweiler L, Thurston SW, Harrington D, Miller RK, Murphy SK, Wang C, Brunner J, Ge Y, Lin Y, Hopke PK, O'Connor TG, Zhang[...]

Knowing Your ABCs: Macrophage ABCA1-Mediated Cholesterol Efflux as a Therapeutic Target in Atherosclerotic Cardiovascular Disease

Karpouzas GA, Ronda N. Knowing Your ABCs: Macrophage ABCA1-Mediated Cholesterol Efflux as a Therapeutic Target in Atherosclerotic Cardiovascular Disease. JACC Basic Transl Sci. 2024 Dec[...]

Risk Profile and Prognostic Implications of Premature Advanced Coronary Atherosclerotic Disease Among Young to Early Middle-aged Adults: The Coronary Artery Calcium Consortium

Boakye E, Dehesh M, Dardari Z, Obisesan OH, Osei AD, Dzaye O, Jha K, Rozanski A, Berman DS, Budoff MJ, Miedema MD, Nasir K, Rumberger[...]